A Novel Reduction Strategy of Clarithromycin Resistance in Helicobacter pylori

BACKGROUND: Antibiotic resistance is a major therapeutic problem in patients infected with Helicobacter pylori. H. pylori clarithromycin resistant mutants have been evolved during antibiotic therapy, this is mainly due to 23s rRNA point mutations. OBJECTIVES: In the present study, we investigated an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadjrobehkar, Omid, Abdollahi, Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335570/
https://www.ncbi.nlm.nih.gov/pubmed/25741431
http://dx.doi.org/10.5812/jjm.13081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335570/
https://www.ncbi.nlm.nih.gov/pubmed/25741431
http://dx.doi.org/10.5812/jjm.13081

Ejemplares similares